Company: HURA
Filing Date: 2025-11-03
Form Type: S-3
Source: 0001193125-25-262843
Chunk: 25

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-11-03
Form: S-3
Chunk 25
---
 in one or more series, 4,721,470 of
which shares are undesignated, with such designations, rights and preferences as may be determined from time to time by our Board. Accordingly, our Board is empowered, without stockholder approval, to issue preferred stock with dividend,
liquidation, conversion, voting, or other rights that could adversely affect the voting power or other rights of the holders of Common Stock.

16

Series A Preferred Stock

Our Board previously established a series of preferred stock designated as Series A Preferred Stock (“Series A Preferred Stock”),
comprising 278,530 shares of preferred stock, of which all shares remain outstanding as of November 3, 2025. Subject to superior rights of any other outstanding preferred stock from time to time each outstanding share of Series A Preferred
Stock is entitled to receive, in preference to Common Stock, cumulative dividends, payable quarterly in arrears, at an annual rate of 3% of $1.00 per share (the “Series A Stated Value”). We have never paid dividends on shares of Common
Stock and we do not intend to do so for the foreseeable future. Series A Preferred Stock does not have any voting rights. In the event of liquidation, each share of Series A Preferred Stock is entitled to receive, in preference to Common Stock, a
liquidation payment equal to the Series A Stated Value (as adjusted for stock splits, stock dividends, combinations or other recapitalizations of the Series A Preferred Stock), plus any accrued and unpaid dividends. If there are insufficient funds
to permit full payment, the assets legally available for distribution will be distributed pro rata among the holders of the Series A Preferred Stock. The Series A Preferred Stock cannot be transferred without our prior written consent.

Certain Anti-Takeover Provisions

Special Meetings of Stockholders

Special meetings of the stockholders may only be called by our Board acting pursuant to a resolution approved by
the affirmative majority of the entire Board, certain officers or any stockholder holding at least 20% of the stock issued and outstanding and entitled to vote thereat.

Business Combinations Act

The
Business Combinations Act, Sections 78.411 to 78.444 of the Nevada Revised Statute (“NRS”), restricts the ability of a Nevada “resident domestic corporation” having at least 200 stockholders of record to engage in any
“combination” with an “interested stockholder” for two (2) years after the date that the person first became an